Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Interrogation of the cellular immunome of cancer patients with regard to the COVID-19 pandemic

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-002087Source: DataRank Database

Interrogation of the cellular immunome of cancer patients with regard to the COVID-19 pandemic is a research paper published in Journal for ImmunoTherapy of Cancer (2021). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.49)OA: goldTopics (70)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Jennifer L. Marté,Meghali Goswami ORCID,Nicole J. Toney ORCID,Yo-Ting Tsai ORCID,James L. Gulley ORCID

Live enrichment

PubMed:33707314 PMC:PMC7956734 OpenAlex:https://openalex.org/W3134837906

Intramural Research Program, Center for Cancer Research, National Cancer Institute, NIH

Grant: ZIA BC 010598, “Human Immune Responses to Tumor

Intramural Research Program, Center for Cancer Research, National Cancer Institute, NIH

Grant: ZIA BC 010666, “Cancer Therapy Clinical Trials U

National Institutes of Health

Grant: 1Z01BC010598-03

Development of Novel Vaccine Strategies

FWCI

0.49

Citation Percentile

0.7%

Citation Trend

2022

2023

2026

goldLicense: cc-by-nc

journalhttps://jitc.bmj.com/content/jitc/9/3/e002087.full.pdf

publisherhttps://jitc.bmj.com/content/jitc/9/3/e002087.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1136/jitc-2020-002087

journalhttps://doi.org/10.1136/jitc-2020-002087

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33707314

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-190301 basic medicine03 medical and health sciences0303 health sciences

MeSH Terms

ImmunosenescenceMyeloid-Derived Suppressor CellsImmune Checkpoint InhibitorsCOVID-19SARS-CoV-2COVID-19 VaccinesAge FactorsB-LymphocytesDendritic CellsDisease SusceptibilityGlucocorticoidsHumansImmunity, InnateKiller Cells, NaturalNeoplasmsSeverity of Illness IndexT-LymphocytesT-Lymphocyte SubsetsCytokinesTumor Necrosis Factor Receptor Superfamily, Member 7ProteomeCD40 LigandGranzymesAdaptive ImmunityB7-H1 AntigenProgrammed Cell Death 1 Receptor

Keywords

Immune systemImmunologyPandemicCancerImmunotherapyVirusCoronavirus disease 2019 (COVID-19)MedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)BiologyDiseaseInternal medicineImmunityT-lymphocytesCellularadaptive immunityCovid-19COVID-19 VaccinesImmunosenescenceCD40 LigandProgrammed Cell Death 1 ReceptorReviewB7-H1 AntigenGranzymesNeoplasmsHumansGlucocorticoidsImmune Checkpoint InhibitorsRC254-282B-LymphocytesMyeloid-Derived Suppressor CellsAge FactorsNeoplasms. Tumors. Oncology. Including cancer and carcinogensDendritic CellsImmunity, InnateKiller Cells, NaturalCytokinesDisease Susceptibility

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Interrogation of the cellular immunome of cancer patients with regard to the COVID-19 pandemic

FAIR Checklist

Authors (7)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)